Volume 23, Issue 3, Pages (March 2016)

Slides:



Advertisements
Similar presentations
Volume 10, Issue 4, Pages (October 2009)
Advertisements

Volume 14, Issue 6, Pages (December 2011)
Volume 9, Issue 5, Pages (December 2014)
Volume 14, Issue 4, Pages (October 2011)
Volume 19, Issue 4, Pages (April 2014)
Volume 3, Issue 3, Pages (March 2006)
Volume 24, Issue 3, Pages (September 2016)
Volume 8, Issue 4, Pages (October 2008)
Volume 23, Issue 2, Pages (February 2016)
Volume 16, Issue 10, Pages (September 2016)
Volume 35, Issue 5, Pages (December 2015)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 24, Issue 6, Pages (December 2016)
Volume 26, Issue 4, Pages e3 (October 2017)
Volume 13, Issue 6, Pages (June 2011)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 2, Pages (August 2013)
Volume 22, Issue 3, Pages (March 2015)
Volume 16, Issue 6, Pages (December 2012)
Volume 21, Issue 11, Pages (December 2017)
Volume 19, Issue 6, Pages (June 2014)
Volume 22, Issue 2, Pages (August 2015)
Volume 14, Issue 3, Pages (September 2011)
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 17, Issue 5, Pages (May 2013)
Volume 25, Issue 2, Pages (February 2017)
A Smooth Muscle-Like Origin for Beige Adipocytes
Volume 14, Issue 2, Pages (August 2011)
Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Volume 16, Issue 6, Pages (December 2012)
Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat
Volume 22, Issue 4, Pages (October 2015)
Volume 9, Issue 2, Pages (February 2009)
Volume 9, Issue 5, Pages (May 2009)
Volume 21, Issue 5, Pages (May 2015)
Volume 17, Issue 8, Pages (November 2016)
Volume 24, Issue 1, Pages (July 2016)
Volume 14, Issue 5, Pages (November 2011)
Volume 11, Issue 3, Pages (March 2010)
Volume 8, Issue 4, Pages (October 2008)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 5, Issue 5, Pages (May 2007)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 3, Pages (September 2007)
Volume 13, Issue 12, Pages (December 2015)
Knockdown of NPY Expression in the Dorsomedial Hypothalamus Promotes Development of Brown Adipocytes and Prevents Diet-Induced Obesity  Pei-Ting Chao,
Volume 25, Issue 5, Pages (October 2018)
High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic Dysfunction  Angeliki Chalkiadaki, Leonard Guarente 
Volume 157, Issue 6, Pages (June 2014)
Volume 8, Issue 5, Pages (November 2008)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Volume 14, Issue 6, Pages (February 2016)
PexRAP Inhibits PRDM16-Mediated Thermogenic Gene Expression
Volume 27, Issue 4, Pages e4 (April 2018)
Volume 20, Issue 4, Pages (October 2014)
Cbx4 Sumoylates Prdm16 to Regulate Adipose Tissue Thermogenesis
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
A Smooth Muscle-Like Origin for Beige Adipocytes
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
a b c d e f Wankhade et al., Supplementary Figure 1
Volume 24, Issue 6, Pages (December 2016)
Haruya Ohno, Kosaku Shinoda, Bruce M. Spiegelman, Shingo Kajimura 
Volume 3, Issue 3, Pages (March 2006)
Volume 16, Issue 3, Pages (September 2012)
Transcriptional Control of Brown Fat Determination by PRDM16
Presentation transcript:

Volume 23, Issue 3, Pages 454-466 (March 2016) A Secreted Slit2 Fragment Regulates Adipose Tissue Thermogenesis and Metabolic Function  Katrin J. Svensson, Jonathan Z. Long, Mark P. Jedrychowski, Paul Cohen, James C. Lo, Sara Serag, Serkan Kir, Kosaku Shinoda, Julia A. Tartaglia, Rajesh R. Rao, Alain Chédotal, Shingo Kajimura, Steven P. Gygi, Bruce M. Spiegelman  Cell Metabolism  Volume 23, Issue 3, Pages 454-466 (March 2016) DOI: 10.1016/j.cmet.2016.01.008 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Identification of Slit2 as a PRDM16-Regulated Secreted Protein in Adipose Cells (A) Representative images from UCP1 immunohistochemistry of inguinal subcutaneous adipose tissues from aP2-PRDM16 or wild-type mice. Scale bar, 100 μm. (B) Normalized thermogenic and beige gene expression in primary inguinal cells from aP2-PRDM16 and wild-type mice at day 7 of differentiation. (C) Heatmap showing relative protein levels in conditioned medium from wild-type or ap2-PRDM16 primary inguinal cells (n = 2 per group) as determined by TMT labeling and mass spectrometry. Shown is a shortlist of detected proteins. Fold change for each individual sample is color coded according to the key. For full gene list, see Table S1. (D) Gene expression of Slit2 and Slit3 in BAT and iWAT from 6-week-old Balb/c mice housed at 30°C thermoneutrality (TN) or exposed to 4°C for the indicated time points (n = 3 per group). (E and F) Gene expression of Ap2, Ucp1, Adipsin, F4/80, Slit2, and Slit3 in iWAT (E) and Slit2 and Slit3 in eWAT (F) from C57/b6 mice fed a chow diet or a high-fat diet for 16 weeks. (G) Primary inguinal cells treated with forskolin for 4 hr before gene-expression analysis of Adiponectin, Ucp1, Slit2, and Slit3. Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 Slit2 Promotes a Thermogenic Program in Cells and in Mice (A and B) Thermogenic gene expression in primary inguinal cells treated for 24 hr with 1 μg/ml Slit2 (A) or lysyl oxidase (LOXL1), glypican1 (GPC1), chordin-like 1 (CHL1), or C-X-C motif chemokine 12 (CXCL12) (B) recombinant proteins at day 6 of differentiation. (C) Western blotting against Slit2 in primary inguinal cells overexpressing LacZ or Slit2-FL. (D) Normalized thermogenic mRNA expression in primary inguinal cells overexpressing Slit2-FL or LacZ. (E) Western blotting against Slit2 in primary inguinal cells from Slit2flox/flox mice transduced with LacZ virus (Slit2flox/flox) or Cre virus (Slit2KO). (F) Gene expression in primary inguinal cells from Slit2flox/flox mice transduced with LacZ virus (Slit2flox/flox) or CRE virus (Slit2KO). (G) Gene expression in BAT tissue from Slit2flox/flox mice infected with GFP-AAV8 (Slit2flox/flox-AAV8-GFP) or Cre virus (Slit2flox/flox-AAV8-CRE). (H) Plasma levels of Slit2 by western blotting in C57/b6 mice injected with adenoviral vectors for Slit2-FL or LacZ at day 7 postinjection. (I–L) Normalized mRNA expression levels in liver (I), quadriceps muscle (J), iWAT (K), and BAT (L) at day 7 postinjection. (M) Representative images from UCP1 immunohistochemistry of iWAT and BAT from C57/b6 mice injected with Slit2-FL or LacZ at day 7. Scale bar, 100 μm. Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 Identification and Characterization of a Slit2 Cleavage Fragment (A) Western blot of overexpressed full-length C-terminal, FLAG-tagged Slit2 detected with a Slit2 antibody (left) and an anti-FLAG antibody (right). Boxed immunoreactive bands were analyzed using mass spectrometry (see Experimental Procedures). (B) Matched peptides to Slit2-FL or Slit2-C (bold blue) using C-terminal, FLAG-tagged Slit2-overexpression conditioned medium. (C) Cloning scheme for Slit2 full-length protein, Slit2-N, and Slit2-C protein. (D–F) Western blotting of overexpressed LacZ, Slit2-N, and Slit2-C in primary inguinal cells (D), liver (E), or plasma (F) detected with a V5-HRP antibody. Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 Slit2-C Is Sufficient to Recapitulate the Thermogenic Activity of Full-Length Slit2 (A and B) Normalized thermogenic mRNA expression in primary inguinal cells expressing LacZ or Slit2-C (A), or primary brown fat cells overexpressing LacZ, Slit2-C, or Slit2-FL (B). (C and D) Thermogenic mRNA expression in iWAT (C) and BAT (D) in mice injected with LacZ or Slit2-C adenovirus at day 7. (E) UCP1 immunohistochemistry of iWAT (upper panel) and BAT (lower panel) from mice injected with Slit2-C or LacZ at day 7. Scale bar, 100 μm. (F) O2 consumption in iWAT (left panel) and BAT (right panel) from mice injected with Slit2-C or LacZ at day 7. n = 10 per group. Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 5 Increased Circulating Slit2-C Augments Whole-Body Energy Expenditure and Improves Glucose Homeostasis in Obese Mice (A–E) Whole-body energy expenditure in DIO C57/b6 mice under 6 days after injection with LacZ or Slit2-C adenovirus. (A) O2 consumption, (B) RER, (C) locomotor activity, (D) accumulated food intake, and (E) averaged oxygen consumption at days 5–7 in mice with no significant difference in body weight between the groups. (F) Tissue weights of BAT, iWAT, and eWAT at day 7 postinjection with LacZ or Slit2-C adenovirus. (G and H) Body weight (G) and intraperitoneal glucose-tolerance test (H) in 16-week-old DIO mice injected with Slit2-C or LacZ performed at day 7 (n = 9–10). Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 6 Slit2-C Induces a Thermogenesis Program through the PKA Signaling Pathway in Adipocytes (A) Primary inguinal cells treated with Slit2-C or LacZ adenovirus at day 2 of differentiation (108 pfu/well), starved overnight at day 6, and analyzed at day 7 by western blotting for phospho- and total proteins for epidermal growth-factor receptor (EGFR), ERK1/2, and AMPK. (B) Primary cells treated as in (A) and blotted for phosphorylated PKA substrates, phospho- and total HSL, UCP1, and α-tubulin. As a positive control, similar samples were treated with 100 nM NE for 30 min. (C) Primary cells treated as in (A) and blotted for phospho- and total ATGL and phosphorylated PKC substrates. (D) Quantification of UCP1 protein levels relative to α-tubulin in (B); n = 3. (E) Western blot analysis for PKA-substrate phosphorylation upon acute treatment (30 min) with conditioned medium from cells expressing LacZ, Slit2-FL, or Slit2-C. (F–H) Thermogenic gene expression in primary inguinal cells overexpressing Slit2-C or LacZ at day 7 and treated with β-receptor antagonist propranolol (100 nM) for 24 hr (F), PKA inhibitor H89 (30 μM) for 2 hr (G), or adenylyl cyclase inhibitor SQ-22536 (10 μM) for 24 hr (H). (I) Silver stain of immunopurified Slit2-C FLAG protein compared with an albumin standard. (J) Western blot of immunopurified Slit2-C FLAG protein using antibodies for FLAG or Slit2. (K) Cell-surface binding of FLAG peptide or Slit2-C protein to primary inguinal adipocytes. (L) Treatment of primary inguinal cells with 20 nM NE or 20 nM Slit2-C protein for 0, 5, 15, 30, 60, and 90 min. (M) Normalized gene expression in primary inguinal cells after treatment with Slit2-C protein for 2 hr. Comparisons are presented as Slit2-C versus LacZ (∗), LacZ versus Slit2-C with drug treatment (#), or LacZ versus drug treatment ($). Data are presented as mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Cell Metabolism 2016 23, 454-466DOI: (10.1016/j.cmet.2016.01.008) Copyright © 2016 Elsevier Inc. Terms and Conditions